Antiproliferative in vitro effects of BI 2536-mediated PLK1 inhibition on cervical adenocarcinoma cells. (Q54550277)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Antiproliferative in vitro effects of BI 2536-mediated PLK1 inhibition on cervical adenocarcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

cervical adenocarcinoma

1 reference

inferred from title

author

Julia Alejandra Pezuk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

María S Brassesco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Carlos Scrideli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jaqueline C Oliveira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Elza T Sakamoto-Hojo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Luiz Gonzaga Tone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

4

Andressa G Morales

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

Ana P Montaldi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

12 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Medicine

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

75-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10238-011-0166-1

16 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Expression profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-011-0166-1

The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22080235

12 December 2020

inferred from PubMed ID database lookup

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22080235

12 December 2020

inferred from PubMed ID database lookup

Tumor regression by combination antisense therapy against Plk1 and Bcl-2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22080235

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10238-011-0166-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080235%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference